Keisuke Kato

7PUBLICATIONS
32CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NeonatologyHaematological tumoursRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 19, 2025
Establishment and characterization of a novel cell line ICH-BCPALL-3 from B cell precursor acute lymphoblastic leukemia with TCF3::HLF.

Keisuke Kato, Ioannis Panagopoulos, Ai Yoshimi

|Jun 10, 2025
A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

Yuichi Kodama, Masanori Nishi, Atsushi Sato

|Oct 14, 2024
Establishment and Characterization of a Novel Pleuropulmonary Blastoma Cell Line.

Keisuke Kato, Hiroaki Goto, Mio Tanaka

|Aug 05, 2024
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.

Shota Kato, Kentaro Nakashima, Genki Yamato

|Jul 30, 2024
Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor.

Keisuke Kato, Jun-Ichi Nagai, Hiroaki Goto

|Jan 29, 2022
Pernicious anemia associated with Kabuki syndrome.

Satoru Matsushima, Keisuke Kato, Ai Yoshimi

Pageof 2

Frequent Collaborators

1 joint publications

Junko Takita

1 joint publications

Satoru Matsushima

1 joint publications

Ai Yoshimi

1 joint publications

Shota Kato